KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for AbbVie (ABBV) over the last 15 years, with Q3 2025 value amounting to $1.8 billion.

  • AbbVie's Shares Outstanding (Diluted Average) changed 0.0% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.8 billion for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, AbbVie's Shares Outstanding (Diluted Average) stood at $1.8 billion, which was down 0.0% from $1.8 billion recorded in Q2 2025.
  • AbbVie's Shares Outstanding (Diluted Average)'s 5-year high stood at $1.8 billion during Q1 2022, with a 5-year trough of $1.8 billion in Q3 2023.
  • Moreover, its 5-year median value for Shares Outstanding (Diluted Average) was $1.8 billion (2023), whereas its average is $1.8 billion.
  • Per our database at Business Quant, AbbVie's Shares Outstanding (Diluted Average) soared by 1960.92% in 2021 and then fell by 28.14% in 2023.
  • Quarter analysis of 5 years shows AbbVie's Shares Outstanding (Diluted Average) stood at $1.8 billion in 2021, then increased by 0.06% to $1.8 billion in 2022, then dropped by 0.28% to $1.8 billion in 2023, then changed by 0.0% to $1.8 billion in 2024, then dropped by 0.06% to $1.8 billion in 2025.
  • Its last three reported values are $1.8 billion in Q3 2025, $1.8 billion for Q2 2025, and $1.8 billion during Q1 2025.